Mapping the Embryonic Epigenome, Ludwig Institute For Cancer Research (LICR), Salk Institute for Biological Studies, and Morgridge Insitute for Research Study
5/10/2013 7:50:28 AM
More...
|
4-Antibody AG and the Ludwig Institute For Cancer Research (LICR) Expand Oncology Antibody R&D Program With Three New Targets
1/29/2013 11:04:22 AM
More...
|
Powerful Sequencing Technology Decodes DNA Folding Pattern, Ludwig Institute For Cancer Research (LICR) Study
4/12/2012 7:03:17 AM
More...
|
4-Antibody AG Forms Multi-target Oncology Research and Development Alliance with the Ludwig Institute For Cancer Research (LICR)
5/24/2011 10:27:30 AM
More...
|
Ludwig Institute For Cancer Research (LICR) and Polaris Form Collaboration to Expand Development of Polaris' Novel Cancer Drug, ADI-PEG 20
5/18/2011 9:15:10 AM
More...
|
Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Discover That DAVANAT(R) Enhances the Ability of Anti-Tumor T Lymphocytes to Kill Tumor Cells
4/20/2011 8:45:23 AM
More...
|
Lethal Brain Tumor's Strength May Be a Weakness as Well, Reveals Ludwig Institute For Cancer Research (LICR)
8/17/2010 6:20:19 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Announces Significant Advance in Defining DAVANAT(R)'s Mechanism of Action Based on Experiments Done at the University of Minnesotaand the Ludwig Institute For Cancer Research (LICR) in Brussels, Belgium
12/17/2009 9:39:03 AM
More...
|
The Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Collaborate to Test DAVANAT(R)'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes
12/15/2009 9:03:48 AM
More...
|
Serametrix Partners with the Ludwig Institute For Cancer Research (LICR) to Develop and Commercialize Serum-Based Diagnostics
10/14/2009 7:26:48 AM
More...
|
|